Abstract:Background The prescription of injectable anticipatory medications ahead of possible need for last-days-of-life symptom relief is established community practice internationally. Healthcare teams and policy makers view anticipatory medication as having a key role in optimising effective and timely symptom control. However, how these medications are subsequently administered (used) is unclear and warrants detailed investigation to inform interdisciplinary practice and guidance. Objective To identify the frequency, timing and recorded circumstances of the administration of injectable end-of-life anticipatory medications prescribed for patients living at home and in residential care. Design A retrospective mixed-methods observational study using general practitioner (family doctor) and community nursing held clinical records. Setting(s) Community-based care in two English counties. Participants 167 deceased adult patients (aged 18+) registered with eleven general practitioner practices and two associated community nursing services. These were patients prescribed anticipatory medications, identified from the 30 most recent deaths per practice. Patients died between 1 March 2017 and 25 September 2019, from any cause except trauma, sudden death or suicide. Methods Patient characteristics, anticipatory medications discussions, recorded administration contexts and decision-making, medication details, recorded symptom control and comfort at death were collected from clinical records. Data analysis combined quantitative and qualitative analyses in a mixed methods approach. Results Anticipatory medications were administered to 59 % (100/167) patients, commenced between 0 and 586 days before death (median 3 days). Their usage was similar for patients who died from cancer and non-cancer conditions. Anticipatory medications were almost universally started and titrated by visiting nurses. Eleven patients had medications started between 59 days and 586 days before death for recorded reversible non-end-of-life care conditions. Only 5 % (5/100) of patient records contained detailed accounts of patient participation in decisions to start medications: four were recorded as being reluctant to commence medications but agreed to trial injections to relieve symptoms. Crucially, there was recurrent under-recording of the effectiveness of injectable medications and patient comfort. Conclusions Prescribed medications were commonly administered by visiting community nurses to help manage last-days-of-life symptoms. However, patient records infrequently referred to the effectiveness of administered medication and perceived patient comfort. Most recorded references to the patient and family preferences for involvement in anticipatory medication decision-making and their experiences of care are brief and perfunctory. More detailed information should be routinely recorded in clinical records to enable assessment of appropriate and effective use of anticipatory medicines and how inter-professional collaboration and services could be developed to provide adequate twenty-four-hour cover. Tweetable abstract Effectiveness of injectable end-of-life symptom control medications and patient comfort often under-recorded @Ben_Bowers__ @PELi_Cam @TheQNI.

Appropriate use of medication among home care adult cancer patients at end of life: a retrospective observational study

End-of-Life Antibiotherapy: Factors Associated With Prescription

Pharmacological Prescription at the End of Life: Quality Assessment in the Transition of Care to a Community Palliative Care Support Team

Oncology Therapy at the End of Life

Family caregivers' administration of medications at the end-of-life in China: a qualitative study

Polypharmacy and Potentially Inappropriate Medications in Patients With Advanced Cancer: Prevalence and Associated Factors at the End of Life

Drug utilization and medication costs at the end of life

Potentially inappropriate medication use in older patients with breast and colorectal cancer

Potentially inappropriate medication use based on two deprescribing criteria and related factors in patients with terminal cancer: A cross-sectional study

Mixed-Methods Study of End-of-Life Experiences of Patients With Hematologic Malignancies in Social Hospice Residential Home Care Settings

Scoping review of anticancer drug utilization in lung cancer patients at the end of life

Administering injectable medications prescribed in the anticipation of the end of life in the community: A mixed-methods observational study

Home-based care models for patients with terminal illnesses in low and middle-income countries: A systematic review of randomized and quasi-experimental studies

Optimizing medication therapy in elderly patients: The impact of medication review using STOPP and START criteria version 2

Assessment of polypharmacy, potentially inappropriate medications, and drug-drug interactions in older patients with cancer

The Use of Antibiotics at the End of Life: A Cross-Sectional Study

A single-center retrospective analysis of interventions provided to geriatric inpatients receiving end-of-life care

Primary care usage at the end of life: a retrospective cohort study of cancer patients using linked primary and hospital care data

Intensity of End of Life Care for Hematologic Malignancy Patients in Western Washington, United States and Alberta, Canada

Association between Inappropriate End-of-Life Cancer Care and Specialist Palliative Care: A Retrospective Observational Study in Two Acute Care Hospitals

Palliative care needs of advanced cancer patients in the emergency department at the end of life: an observational cohort study